population-basedstudy[J].CancerEpidemiol,2019,60:106-111.[6]ATREID,WATANEGV,HARISINGHANIMG.Malignantperitonealmesothelioma:cor-relationbetweenCTimagingfeaturesandhis-tologicsubtypes[J].AbdomRadiol(NY),2021,46(11):5105-5113.[7]MIYAGAWAC,TAKAYAH,SAKAIK,etal.AnovelmalignantperitonealmesotheliomawithSTRNexon2andALKexon20:Acasereportandliteraturereview[J].Oncologist,2021,26(5):356-361.[8]KITADAIR,SHIMOIT,SUDOK,etal.Effi-cacyofsecond-linetreatmentandprognosticfactorsinpatientswithadvancedmalignantperitonealmesothelioma:Aretrospectivestudy[J].BMCCancer,2021,21(1):294.[9]江路,杨乐,杨子萱,等.3例恶性腹膜间皮瘤的临床表现和基因突变特点分析及文献回顾[J].现代肿瘤医学,2022,30(13):2415-2419.[10]PAND,WANGM,LIUW,etal.Clinical-path-ologicalcharacteristicsandprognosticfactorsformalignantperitonealmesotheliomaintheelderly[J].BMCGastroenterol,2022,22(1):292.[11]杨远园,付瑞敏,王进京,等.表现为良性肿瘤的干痛型腹膜恶性间皮瘤1例[J].安徽医药,2021,25(12):2391-2393.[12]GILANIS,MEHTAA,GARCIA-FADRIQUEA,etal.Outcomesofcytoreductivesurgerywithhyperthermicintraperitonealchemothera-pyforperitonealmesotheliomaandpredictorsofsurvival[J].IntJHyperthermia,2018,34(5):578-584.[13]ODDONEE,BOLLONJ,NAVACR,etal.EffectofasbestosconsumptiononmalignantpleuralmesotheliomainItaly:Forecastsofmortalityupto2040[J].Cancers(Besel),2021,13(13):3338.[14]李雨萌,王学梅,桑亮,等.盆腔腹膜恶性间皮瘤1例并文献复习[J].中国临床医学影像杂志,2021,32(3):221-222.[15]ODDONEE,BOLLONJ,NAVACR,etal.ForecastofmalignantperitonealmesotheliomamortalityinItalyupto2040[J].IntJEnvironResPublicHealth,2020,18(1):160.[16]LIUY,WUJ,ZHAOY,etal.Localizedbiphasicmalignantmesotheliomapresentingasagiantpel-vicwallmass:Ararecasereportandliteraturere-view[J].BMCMedImaging,2020,20(1):48.(收稿日期:2023-03-04修回日期:2023-08-03)·案例分析·经皮冠状动脉介入治疗后胆囊内造影剂充盈合并急性胆囊炎1例*周怡伶1,马建新2△,李文倩3(1.南方医科大学,广东广州510515;2.中国人民解放军第三〇五医院干部病房,北京100034;3.中国人民解放军总医院第六医学中心肾脏病科,北京100080)[摘要]出血...